Lundbeck
HLUN-B.CO
#2582
Rank
S$7.28 B
Marketcap
$7.64
Share price
-0.98%
Change (1 day)
21.28%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.48

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.48. In 2022 the company made an earnings per share (EPS) of $0.36 a decrease over its 2021 EPS that were of $0.82.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.4832.28%
2022$0.36-55.47%
2021$0.82-51.83%
2020$1.70-28.01%
2019$2.36-44.08%
2018$4.2251.94%
2017$2.78126.64%
2016$1.23-120.84%
2015-$5.885622.18%
2014-$0.10-110.03%
2013$1.02-28.08%
2012$1.42-52.1%
2011$2.97-1.31%
2010$3.0115.61%
2009$2.61